Short answer
Quanterix Corp (QTRX) filed an 8-K current report with the SEC on August 10, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Q2 fiscal 2026 results for quarter ended June 30, 2026.
Quanterix Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 fiscal 2026 results for quarter ended June 30, 2026
- Earnings Release issued August 10, 2026
- Detailed financial results and management commentary in Exhibit 99.1
Item 7.01 · Regulation FD Disclosure
- Earnings-call slides furnished as Exhibit 99.2 for August 10, 2026
- Jim Gute appointed Chief Commercial Officer, signaling a commercial leadership change
- Appointment press release furnished as Exhibit 99.3
- Exhibits 99.1–99.3 not treated as filed under Section 18 or incorporated into other filings
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $32.9M, up 34% YoY, but below expectations, prompting commercial reorganization and leadership changes
- 2026 revenue outlook cut to $142–148M from $169–174M, signaling continued academic and pharmaceutical market softness
- Cash-flow breakeven delayed to 2027; year-end cash forecast reduced to approximately $80M from $100M
- Cash and marketable securities totaled $96.9M; adjusted Q2 cash usage improved to $4.0M
- $26.9M Akoya goodwill impairment drove GAAP net loss to $48.9M; non-cash charge does not reduce liquidity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Quanterix Corp 8-K filings
Get the next QTRX 8-K as it lands
Follow QTRX for push alerts, or ask the research agent what this filing means.